Best Care Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2627.55%
- Profit Growth 61.36%
- Ebitda -129.53%
- Net Worth -6.07%
- Total Assets 182.50%
About Best Care Pharmaceuticals
Best Care Pharmaceuticals Private Limited (BCPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2020 (Four years and seven months 1 days old ). Its registered office is in Haridwar, Uttarakhand, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Varsha Tyagi, Vandana Tyagi, and Priyanka serve as directors at the Company.
Company Details
- Location
Haridwar, Uttarakhand, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24100UR2020PTC011197
- Company No.
011197
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Who are the key members and board of directors at Best Care Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varsha Tyagi  | Director | 24-Jul-2020 | Current |
| Vandana Tyagi | Director | 24-Jul-2020 | Current |
| Priyanka | Director | 24-Jul-2020 | Current |
Financial Performance of Best Care Pharmaceuticals.
Best Care Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 2627.55% increase. The company also saw a substantial improvement in profitability, with a 61.36% increase in profit. The company's net worth dipped by a decrease of 6.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Best Care Pharmaceuticals?
Unlock access to Best Care Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Best Care Pharmaceuticals?
Best Care Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Best Care Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Best Care Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.